Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tivantinib

EU orphan designation number: EU/3/13/1202   
Active ingredient: Tivantinib
Indication: Treatment of hepatocellular carcinoma
Sponsor: Daiichi Sankyo Europe GmbH
Zielstattstrasse 48, 81379 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/115/13 (2013)8048 of 13/11/2013
10/08/2016 Transfer of orphan designation EMA/OD/115/13/T/01 (2016)5271 of 08/08/2016